Lapatinib Completed Phase 1 Trials for Stage IV Breast Cancer / Male Breast Cancer / Her2-Positive Breast Cancer / Recurrent Breast Cancer / Unspecified Adult Solid Tumor, Protocol Specific / Stage IIIC Breast Cancer / Stage IIIB Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00389922Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
NCT00662636Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
NCT01245205Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer